Page 33 - JCTR-9-6
P. 33
Lubimova et al. | Journal of Clinical and Translational Research 2023; 9(6): 392-397 397
Avčin T, Toplak N. Vaccination Coverage in Children Immunosuppressed Patients with Inflammatory Rheumatic
with Rheumatic Diseases. Clin Exp Rheumatol 2020;38: Diseases and Healthy Controls. Vaccine 2022;40:
164-70. 4897-904.
[24] Morin MP, Quach C, Fortin E, Chédeville G. Vaccination [34] Nerome Y, Akaike H, Nonaka Y, Takezaki T, Kubota T,
Coverage in Children with Juvenile Idiopathic Yamato T, et al. The Safety and Effectiveness of HBV
Arthritis Followed at a Paediatric Tertiary Care Centre. Vaccination in Patients with Juvenile Idiopathic Arthritis
Rheumatology (Oxford) 2012;51:2046-50. Controlled by Treatment. Mod Rheumatol 2016;26:
[25] Minden K, Niewerth M, Borte M, Singendonk W, 368-71.
Haas JP. Impfungen bei Rheumatischen Erkrankungen [35] Heijstek MW, Kamphuis S, Armbrust W, Swart J, Gorter S,
des Kindes-und Jugendalters [Immunization in Children de Vries LD, et al. Effects of the Live Attenuated Measles-
and Adolescents with Rheumatic Diseases]. Z Rheumatol Mumps-Rubella Booster Vaccination on Disease Activity in
2007;66:111-2, 114-8, 120. Patients with Juvenile Idiopathic Arthritis: A Randomized
[26] Crawford NW, Buttery JP. Adverse Events Following Trial. JAMA 2013;309:2449-56.
Immunizations: Fact and Fiction. Paediatr Child Health [36] Uziel Y, Moshe V, Onozo B, Kulcsár A, Tróbert-
2013;23:121-4. Sipos D, Akikusa JD, et al. Live Attenuated MMR/V
[27] Silva CA, Terreri MT, Aikawa NE, Carvalho JF, Pileggi GC, Booster Vaccines in Children with Rheumatic Diseases
Ferriani VP, et al. Vaccination Practice in Children with on Immunosuppressive Therapy are Safe: Multicenter,
Rheumatic Disease. Rev Bras Reumatol 2010;50:351-61. Retrospective Data Collection. Vaccine 2020;38:2198-201.
[28] Vazhappilly S, Vanderkooi O, Benseler S, Gerschman T, [37] Hamad Saied M, van Straalen JW, de Roock S, de Joode-
Johnson N, Luca N, et al. Immunization Status and Barriers Smink GC, Swart JF, Wulffraat NM, et al. Safety of
in Childhood Rheumatic Diseases (Abstract). American Measles-Mumps-Rubella Booster Vaccination in Patients
College of Rheumatology/Association of Rheumatology with Juvenile Idiopathic Arthritis: A Long-Term Follow-up
Health Professionals Annual Meeting; 2014. Study. Vaccine 2023;41:2976-81.
[29] Riaz A, Husain S, Yousafzai MT, Nisar I, Shaheen F, [38] Alfayadh NM, Gowdie PJ, Akikusa JD, Easton ML,
Mahesar W, et al. Reasons for Non-Vaccination and Buttery JP. Vaccinations Do Not Increase Arthritis Flares in
Incomplete Vaccinations Among Children in Pakistan. Juvenile Idiopathic Arthritis: A Study of the Relationship
Vaccine 2018;36:5288-93. between Routine Childhood Vaccinations on the Australian
[30] Brunner HI, Tzaribachev N, Cornejo GV, Joos R, Gervais E, Immunisation Schedule and Arthritis Activity in Children
Cimaz R, et al. Maintenance of Antibody Response to with Juvenile Idiopathic Arthritis. Int J Rheumatol
Diphtheria/Tetanus Vaccine in Patients Aged 2-5 Years 2020;2020:1078914.
with Polyarticular-Course Juvenile Idiopathic Arthritis [39] Toplak N, Uziel Y. Vaccination for Children on Biologics.
Receiving Subcutaneous Abatacept. Pediatr Rheumatol Curr Rheumatol Rep 2020;22:26.
Online J 2020;18:19. [40] Kostik MM, Lubimova NA, Fridman IV, Goleva OV,
[31] Heijstek MW, van Gageldonk PG, Berbers GA, Kharit SM. The Vaccine Coverage and Vaccine Immunity
Wulffraat NM. Differences in Persistence of Measles, Status and Risk Factors of Non-Protective Levels of
Mumps, Rubella, Diphtheria and Tetanus Antibodies Antibodies Against Vaccines in Children with Juvenile
between Children with Rheumatic Disease and Healthy Idiopathic Arthritis: Cross-Sectional Russian Tertiary
Controls: A Retrospective Cross-Sectional Study. Ann Centre Study. Pediatr Rheumatol Online J 2021;19:108.
Rheum Dis 2012;71:948-54. [41] Bednarek A, Klepacz R. Vaccinology Education of Nurses
[32] Bühler S, Jaeger VK, Adler S, Bannert B, Brümmerhoff C, and the Current Immunoprophylaxis Recommendations
Ciurea A, et al. Safety and Immunogenicity of Tetanus/ for Children with Juvenile Idiopathic Arthritis. J Clin Med
Diphtheria Vaccination in Patients with Rheumatic 2020;9:3736.
Diseases-A Prospective Multi-Centre Cohort Study. [42] Davies K, Woo P, British Paediatric Rheumatology Group.
Rheumatology (Oxford) 2019;58:1585-96. Immunization in Rheumatic Diseases of Childhood:
[33] Mischlinger J, Jaeger VK, Ciurea A, Gabay C, An Audit of the Clinical Practice of British Paediatric
Hasler P, Mueller RB, et al. Long-Term Persistence of Rheumatology Group Members and a Review of the
Antibodies After Diphtheria/Tetanus Vaccination in Evidence. Rheumatology (Oxford) 2002;41:937-41.
Publisher’s note
AccScience Publishing remains neutral with regard to jurisdictional
claims in published maps and institutional affiliations.
DOI: http://dx.doi.org/10.18053/jctres.09.202306.23-00103

